Skip to main content
Account

Table 1 Mutations associated with ciprofloxacin resistance acquired by PA123 during passages with and without exposure of ciprofloxacin

From: Effects of repeated culture in sub-inhibitory concentrations of ciprofloxacin on resistance and genetic characteristics of an ocular Pseudomonas aeruginosa isolate

Passage

MIC

Sub-MIC

Effect

Gene

Product

Mutation status

Growth in sub-MIC ciprofloxacin

P1

1

0.5

Leu240fs

mexS

Oxidoreductase MexS

✦ Appeared at P1; maintained through P31

P4

2

0.5

Val29Gly

GNQ09_02850

Sigma-70 family RNA polymerase sigma factor

✧ Appeared at P4; not maintained (absent from P7 onwards)

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P7

4

1

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P9

8

2

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Appeared at P9; maintained through P31

Thr83Ile

gyrA

DNA gyrase subunit A

✧ Appeared at P9; not maintained (absent from P10 onwards)

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P10

16

4

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Ala51Val

gyrA

DNA gyrase subunit A

✧ Appeared at P10; not maintained (absent from P12 onwards)

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P12

32

8

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Asp87Tyr

gyrA

DNA gyrase subunit A

✦ Appeared at P12; maintained through P31

Ala570dup

gyrA

DNA gyrase subunit A

✦ Appeared at P12; maintained through P31

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P15

64

16

His137fs

GNQ09_05810

Hypothetical protein

✦ Appeared at P15; maintained through P31

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Asp87Tyr

gyrA

DNA gyrase subunit A

✦ Maintained

Ala570dup

gyrA

DNA gyrase subunit A

✦ Maintained

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P18

64

32

His137fs

GNQ09_05810

Hypothetical protein

✦ Maintained

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Asp87Tyr

gyrA

DNA gyrase subunit A

✦ Maintained

Ala570dup

gyrA

DNA gyrase subunit A

✦ Maintained

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

Growth in absence of any ciprofloxacin

P19

64

0

His137fs

GNQ09_05810

Hypothetical protein

✦ Maintained

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Asp87Tyr

gyrA

DNA gyrase subunit A

✦ Maintained

Ala570dup

gyrA

DNA gyrase subunit A

✦ Maintained

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P26

64

His137fs

GNQ09_05810

Hypothetical protein

✦ Maintained

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Asp87Tyr

gyrA

DNA gyrase subunit A

✦ Maintained

Ala570dup

gyrA

DNA gyrase subunit A

✦ Maintained

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

P31

64

His137fs

GNQ09_05810

Hypothetical protein

✦ Maintained

Arg342His

GNQ09_09635

EAL domain-containing protein

✦ Maintained

Asp87Tyr

gyrA

DNA gyrase subunit A

✦ Maintained

Ala570dup

gyrA

DNA gyrase subunit A

✦ Maintained

Leu240fs

mexS

Oxidoreductase MexS

✦ Maintained

Changes to PA123 during growth without ciprofloxacin (control)

P18C

1

0

Pro270Gln

tagH

Type VI secretion system-associated FHA domain protein TagH

Background mutation; not resistance-related

P31C

Pro270Gln

tagH

Type VI secretion system-associated FHA domain protein TagH

Background mutation; not resistance-related

Arg48Pro

GNQ09_25310

DUF692 family protein

Background mutation; not resistance-related

  1. fs frameshift mutation, dup duplication, ✦ mutation appeared and was maintained in all subsequent passages;✧ mutation appeared transiently and was not maintained in subsequent passages; P ciprofloxacin-exposed passage, C antibiotic-free control passage